Opyl: Receives over $200k in R&D tax refund
- Opyl (OPL) has received a research and development (R&D) tax refund of $200,500 from the Australian Taxation Office (ATO)
- The company continuing to undertake the research and development of three digital health platforms that powered by artificial intelligence
- Even though COVID-19 has impacted many businesses in a negative way, it has actually helped verify Opyl’s platforms
- By using Opyl’s digital platforms, clinicians are also given insights and easy to use solutions to help them manage an illness, injury or disorder
- Clinicians are relying on each other like never before for advice and insights based on experiences that have had
- Opyl has ended the day with no change to its share price. Shares are trading for seven cents each